Previous Article | Next Article ![]()
Journal of Clinical Microbiology, January 2008, p. 388-391, Vol. 46, No. 1
0095-1137/08/$08.00+0 doi:10.1128/JCM.01660-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.
| CASE REPORT |

Division of Mycology, Department of Parasitology, Faculty of Medicine, University of Indonesia, Jakarta, Indonesia,1 Division of Tropical and Infectious Diseases, Department of Internal Medicine, Faculty of Medicine, University of Indonesia, Jakarta, Indonesia,2 Centraal Bureau voor Schimmelcultures, Utrecht, The Netherlands,3 Department of Medical Microbiology and Infectious Diseases, Canisius Wilhelmina Hospital, Nijmegen, The Netherlands,4 Division of Allergy and Clinical Immunology, Department of Internal Medicine, Faculty of Medicine, University of Indonesia, Jakarta, Indonesia,5 Department of Parasitology, Faculty of Medicine, Indonesian Christian University, Jakarta, Indonesia,6 Department of Medicine, Division of Acute Medicine and Infectious Diseases, University Medical Centre, Utrecht, The Netherlands7
Received 21 August 2007/ Returned for modification 11 October 2007/ Accepted 1 November 2007
Candida nivariensis was isolated from an Indonesian human immunodeficiency virus-infected patient who suffered from oropharyngeal candidiasis and was identified with molecular tools. Our isolate demonstrated low MICs to amphotericin B, flucytosine, posaconazole, caspofungin, and isavuconazole and was susceptible to fluconazole, itraconazole, and voriconazole.
Published ahead of print on 14 November 2007.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»